Ewa Olszewska Selected Research

Hexosaminidases (Hexosaminidase)

9/2015	Fibroblast-Like Synovial Cells in Rheumatoid Arthritis--the Impact of Infliximab on Hexosaminidase Activity.
1/2014	The activity of N-acetyl-β-d-hexosaminidase A and B and β-glucuronidase in nasal polyps and hypertrophic nasal concha.
6/2012	Cholesteatoma-associated pathogenicity: potential role of lysosomal exoglycosidases.
2/2010	[The pirymethamine influence on hexosoaminidase gene expression in synovial cell culture--preliminary report].
12/2009	[Possible involvement of hexosaminidase in vocal polyps--preliminary report].
7/2009	Hexosaminidase as a new potential marker for larynx cancer.
11/2006	Hexosaminidase as a new potential marker for middle ear cholesteatoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ewa Olszewska Research Topics

Disease

14	Cholesteatoma 03/2016 - 05/2002
5	Obstructive Sleep Apnea 12/2020 - 01/2007
5	Neoplasms (Cancer) 01/2019 - 01/2002
4	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019 - 07/2009
4	Hemorrhage 03/2014 - 07/2006
3	Inflammation (Inflammations) 01/2017 - 01/2014
3	Snoring 07/2014 - 02/2007
3	Nasal Polyps (Nasal Polyp) 01/2014 - 01/2008
3	Middle Ear Cholesteatoma 06/2012 - 11/2006
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 12/2010
2	Rheumatoid Arthritis 09/2015 - 02/2010
2	Rhinosinusitis 03/2014 - 09/2010
2	Hearing Loss (Hearing Impairment) 07/2012 - 01/2004
2	Polyps 12/2009 - 01/2008
2	Granuloma 01/2008 - 01/2004
2	Bone Resorption 07/2007 - 01/2004
2	Asthma (Bronchial Asthma) 01/2007 - 07/2006
1	Airway Obstruction (Choking) 01/2022
1	Apnea 08/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Carcinogenesis 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Lymphatic Metastasis 01/2019
1	Varicose Veins (Varicose Vein) 07/2014
1	Congenital Cholesteatoma 02/2013
1	Oral Lichen Planus 01/2013
1	Conductive Hearing Loss 07/2012
1	Mixed Conductive-Sensorineural Hearing Loss 07/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2010
1	Hypertrophy 01/2010
1	Cysts 11/2009
1	Pathologic Constriction (Stenosis) 01/2008
1	Rhinophyma 01/2008
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2008
1	Pleomorphic Adenoma 01/2008
1	Vascular Malformations 01/2008
1	Otitis Media 07/2007

Drug/Important Bio-Agent (IBA)

7	EnzymesIBA 03/2016 - 11/2006
7	Hexosaminidases (Hexosaminidase)IBA 09/2015 - 11/2006
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2013
4	beta-N-AcetylhexosaminidasesIBA 07/2009 - 01/2007
3	GlycoconjugatesIBA 01/2014 - 07/2007
3	Glycoside Hydrolases (Endoglycosidases)IBA 01/2014 - 07/2007
3	Glycoproteins (Glycoprotein)IBA 06/2012 - 07/2007
3	GlycolipidsIBA 06/2012 - 07/2007
3	Proteoglycans (Proteoglycan)IBA 06/2012 - 07/2007
3	Keratins (Keratin)IBA 11/2009 - 09/2005
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 03/2016
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2019 - 03/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 03/2016
2	CD34 Antigens (CD34 Antigen)IBA 03/2014 - 01/2004
2	GlucuronidaseIBA 01/2014 - 06/2012
2	GalactosidasesIBA 06/2012 - 01/2012
2	Cathepsin DIBA 09/2010 - 05/2002
2	IsoenzymesIBA 01/2008 - 03/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2007 - 07/2006
1	Oxygen (Dioxygen)IBA 08/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	CollagenIBA 01/2017
1	Collagen Type IV (Type IV Collagen)IBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015
1	Infliximab (Remicade)FDA Link 09/2015
1	CytokinesIBA 03/2015
1	LigandsIBA 03/2015
1	Receptor for Advanced Glycation End ProductsIBA 03/2015
1	HMGB1 Protein (HMG1)IBA 03/2015
1	Detergents (Detergent)IBA 07/2014
1	Sodium Tetradecyl Sulfate (Sotradecol)FDA Link 07/2014
1	ElectrolytesIBA 01/2014
1	Hexosaminidase A (Hex A)IBA 01/2014
1	Hexosaminidase BIBA 01/2014
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2013
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 07/2012
1	Indicators and Reagents (Reagents)IBA 03/2012
1	MannosidasesIBA 01/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 12/2010
1	Peptide Hydrolases (Proteases)FDA Link 09/2010
1	pepstatin (pepstatin A)IBA 09/2010
1	Messenger RNA (mRNA)IBA 11/2009
1	Pyrimethamine (Daraprim)FDA Link 11/2009
1	AntibodiesIBA 01/2008
1	alpha-Mannosidase (LAMAN)IBA 07/2007
1	beta-Galactosidase (Lactaid)IBA 07/2007

Therapy/Procedure

7	Operative Surgical Procedures 01/2012 - 01/2002
4	Laryngectomy 01/2019 - 01/2002
2	Therapeutics 01/2022 - 07/2006
2	Nasal Surgical Procedures 12/2020 - 02/2007
2	Gas Lasers 01/2010 - 01/2008
1	Sclerotherapy 07/2014
1	Operative Time 03/2014
1	Photochemotherapy (Photodynamic Therapy) 01/2013
1	Chemoradiotherapy 12/2010
1	Induction Chemotherapy 12/2010
1	Radiotherapy 12/2010
1	Local Anesthesia 01/2010
1	Electrocoagulation (Electrocautery) 01/2008
1	Laser Therapy (Surgery, Laser) 01/2008
1	Semiconductor Lasers 01/2008